<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font21 { font-size : 21; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font28 { font-size : 28; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">retinal </span>
   <span class="font28">diabetic </span>
   <span class="font21">patients </span>
   <span class="font19">Ophthalmology </span>
   <span class="font19">treatment </span>
   <span class="font19">cells </span>
   <span class="font18">retinopathy </span>
   <span class="font18">macular </span>
   <span class="font16">clinical </span>
   <span class="font16">progression </span>
   <span class="font15">treat </span>
   <span class="font15">used </span>
   <span class="font15">study </span>
   <span class="font14">Diabetes </span>
   <span class="font14">intravitreal </span>
   <span class="font14">therapy </span>
   <span class="font14">drug </span>
   <span class="font14">effects </span>
   <span class="font14">{border-style </span>
   <span class="font14">edema </span>
   <span class="font14">cell </span>
   <span class="font14">delivery </span>
   <span class="font14">diabetes </span>
   <span class="font14">px;} </span>
   <span class="font14">retina </span>
   <span class="font14">stem </span>
   <span class="font14">use </span>
   <span class="font13">#ffffff;} </span>
   <span class="font13">DR. </span>
   <span class="font13">shown </span>
   <span class="font13">type </span>
   <span class="font13">DME </span>
   <span class="font13">Research </span>
   <span class="font13">effect </span>
   <span class="font13">rats </span>
   <span class="font13">reported </span>
   <span class="font13">associated </span>
   <span class="font13">trial </span>
   <span class="font13">photoreceptor </span>
   <span class="font13">results </span>
   <span class="font12">VEGF </span>
   <span class="font12">complications </span>
   <span class="font12">dose </span>
   <span class="font12">injection </span>
   <span class="font12">levels </span>
   <span class="font12">phase </span>
   <span class="font12">trials </span>
   <span class="font12">triamcinolone </span>
   <span class="font12">... </span>
   <span class="font12">Clinical </span>
   <span class="font12">However, </span>
   <span class="font12">Medicine </span>
   <span class="font12">agents </span>
   <span class="font12">antioxidant </span>
   <span class="font12">control </span>
   <span class="font12">laser </span>
   <span class="font12">reduce </span>
   <span class="font12">showed </span>
   <span class="font12">vascular </span>
   <span class="font12">Archives </span>
   <span class="font12">DR, </span>
   <span class="font12">Diabetic </span>
   <span class="font12">Science </span>
   <span class="font12">development </span>
   <span class="font12">human </span>
   <span class="font12">new </span>
   <span class="font12">oxidative </span>
   <span class="font12">vessels </span>
   <span class="font12">Agents </span>
   <span class="font12">acid </span>
   <span class="font12">anti-inflammatory </span>
   <span class="font12">approved </span>
   <span class="font12">blood </span>
   <span class="font12">capillary </span>
   <span class="font12">experimental </span>
   <span class="font12">neovascularization </span>
   <span class="font12">pharmacotherapy </span>
   <span class="font12">therapeutic </span>
   <span class="font12">treating </span>
   <span class="font12">vision </span>
   <span class="font12">vitreous </span>
   <span class="font12">Current </span>
   <span class="font12">Effect </span>
   <span class="font12">III </span>
   <span class="font12">Intravitreal </span>
   <span class="font12">PDR </span>
   <span class="font12">activity </span>
   <span class="font12">drugs </span>
   <span class="font12">effective </span>
   <span class="font12">growth </span>
   <span class="font12">increased </span>
   <span class="font12">pathway </span>
   <span class="font12">photocoagulation </span>
   <span class="font12">primary </span>
   <span class="font12">randomized </span>
   <span class="font12">rat </span>
   <span class="font12">stress </span>
   <span class="font12">technology </span>
   <span class="font12">transplantation </span>
   <span class="font12">using </span>
   <span class="font11">Experimental </span>
   <span class="font11">FDA </span>
   <span class="font11">Group </span>
   <span class="font11">Investigative </span>
   <span class="font11">Nature </span>
   <span class="font11">Study </span>
   <span class="font11">Visual </span>
   <span class="font11">acetonide </span>
   <span class="font11">administration </span>
   <span class="font11">antiangiogenic </span>
   <span class="font11">article </span>
   <span class="font11">chronic </span>
   <span class="font11">damage </span>
   <span class="font11">polyol </span>
   <span class="font11">proliferative </span>
   <span class="font11">px; </span>
   <span class="font11">risk </span>
   <span class="font11">tea </span>
   <span class="font11">treated </span>
   <span class="font11">{font-family </span>
   <span class="font11">.// </span>
   <span class="font11">./j.ophtha... </span>
   <span class="font11">American </span>
   <span class="font11">Besides, </span>
   <span class="font11">Drug </span>
   <span class="font11">Further, </span>
   <span class="font11">Moreover, </span>
   <span class="font11">Pharmacology </span>
   <span class="font11">Siegel </span>
   <span class="font11">administered </span>
   <span class="font11">compared </span>
   <span class="font11">controlled </span>
   <span class="font11">corticosteroid </span>
   <span class="font11">degeneration </span>
   <span class="font11">disease </span>
   <span class="font11">efficacy </span>
   <span class="font11">endothelial </span>
   <span class="font11">following </span>
   <span class="font11">font-size </span>
   <span class="font11">glucose </span>
   <span class="font11">improved </span>
   <span class="font11">kinase </span>
   <span class="font11">leading </span>
   <span class="font11">major </span>
   <span class="font11">period </span>
   <span class="font11">photoreceptors </span>
   <span class="font11">pluripotent </span>
   <span class="font11">prevent </span>
   <span class="font11">reducing </span>
   <span class="font11">reduction </span>
   <span class="font11">retinopathy: </span>
   <span class="font11">role </span>
   <span class="font11">severe </span>
   <span class="font11">systemic </span>
   <span class="font11">tested </span>
   <span class="font11">tissue </span>
   <span class="font11">vitamin </span>
   <span class="font11">./archopht... </span>
   <span class="font11">Care </span>
   <span class="font11">Kim </span>
   <span class="font11">Treatment </span>
   <span class="font11">adjunct </span>
   <span class="font11">agent </span>
   <span class="font11">anti-VEGF </span>
   <span class="font11">caused </span>
   <span class="font11">compounds </span>
   <span class="font11">condition </span>
   <span class="font11">demonstrated </span>
   <span class="font11">double; </span>
   <span class="font11">early </span>
   <span class="font11">effects. </span>
   <span class="font11">embryonic </span>
   <span class="font11">expression </span>
   <span class="font11">factor </span>
   <span class="font11">factors </span>
   <span class="font11">inhibitors </span>
   <span class="font11">injections </span>
   <span class="font11">loss </span>
   <span class="font11">model </span>
   <span class="font11">multiple </span>
   <span class="font11">neovascular </span>
   <span class="font11">precursor </span>
   <span class="font11">production </span>
   <span class="font11">protein </span>
   <span class="font11">receptor </span>
   <span class="font11">refractory </span>
   <span class="font11">release </span>
   <span class="font11">review </span>
   <span class="font11">studies </span>
   <span class="font11">sustained </span>
   <span class="font11">./-. </span>
   <span class="font11">./diacare... </span>
   <span class="font11">./iovs.- </span>
   <span class="font11">./j.ajo... </span>
   <span class="font11">BCVA </span>
   <span class="font11">Delivery </span>
   <span class="font11">IVTA </span>
   <span class="font11">Lee </span>
   <span class="font11">Lucentis </span>
   <span class="font11">Medical </span>
   <span class="font11">Nonetheless, </span>
   <span class="font11">Opinion </span>
   <span class="font11">Stem </span>
   <span class="font11">Takahashi </span>
   <span class="font11">addition, </span>
   <span class="font11">age-related </span>
   <span class="font11">antioxidants </span>
   <span class="font11">aspirin </span>
   <span class="font11">biochemical </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">carried </span>
   <span class="font11">changes </span>
   <span class="font11">collab: </span>
   <span class="font11">combination </span>
   <span class="font11">concentration </span>
   <span class="font11">current </span>
   <span class="font11">currently </span>
   <span class="font11">decrease </span>
   <span class="font11">derived </span>
   <span class="font11">designed </span>
   <span class="font11">dexamethasone </span>
   <span class="font11">edema. </span>
   <span class="font11">endophthalmitis </span>
   <span class="font11">eye </span>
   <span class="font11">fenofibrate </span>
   <span class="font11">formation </span>
   <span class="font11">high </span>
   <span class="font11">iPSC </span>
   <span class="font11">improve </span>
   <span class="font11">inhibits </span>
   <span class="font11">leads </span>
   <span class="font11">leakage </span>
   <span class="font11">long-term </span>
   <span class="font11">lower </span>
   <span class="font11">management </span>
   <span class="font11">mechanism </span>
   <span class="font11">mechanisms </span>
   <span class="font11">months </span>
   <span class="font11">potential </span>
   <span class="font11">precursors </span>
   <span class="font11">protective </span>
   <span class="font11">randomized, </span>
   <span class="font11">solid; </span>
   <span class="font11">target </span>
   <span class="font11">topical </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font10">./S-()- </span>
   <span class="font10">./archopht.. </span>
   <span class="font10">./j.-...x </span>
   <span class="font10">./s--- </span>
   <span class="font10">Cells </span>
   <span class="font10">Currently, </span>
   <span class="font10">Early </span>
   <span class="font10">Expert </span>
   <span class="font10">Eye </span>
   <span class="font10">Green </span>
   <span class="font10">Gupta </span>
   <span class="font10">Indian </span>
   <span class="font10">International </span>
   <span class="font10">Kowluru </span>
   <span class="font10">Kumar </span>
   <span class="font10">Kuppermann </span>
   <span class="font10">Macular </span>
   <span class="font10">Ocular </span>
   <span class="font10">Potential </span>
   <span class="font10">Review </span>
   <span class="font10">Reviews </span>
   <span class="font10">Systemic </span>
   <span class="font10">Trial </span>
   <span class="font10">Wilson </span>
   <span class="font10">action </span>
   <span class="font10">activation </span>
   <span class="font10">adipose </span>
   <span class="font10">advances </span>
   <span class="font10">adverse </span>
   <span class="font10">agents. </span>
   <span class="font10">analysis </span>
   <span class="font10">angiogenesis </span>
   <span class="font10">antibody </span>
   <span class="font10">background </span>
   <span class="font10">bevacizumab </span>
   <span class="font10">bold </span>
   <span class="font10">capillaries </span>
   <span class="font10">cause </span>
   <span class="font10">central </span>
   <span class="font10">choroidal </span>
   <span class="font10">comparison </span>
   <span class="font10">considered </span>
   <span class="font10">courier; </span>
   <span class="font10">decreasing </span>
   <span class="font10">degenerative </span>
   <span class="font10">developed </span>
   <span class="font10">device </span>
   <span class="font10">diagnosed </span>
   <span class="font10">differentiate </span>
   <span class="font10">doses </span>
   <span class="font10">edema: </span>
   <span class="font10">effectiveness </span>
   <span class="font10">em; </span>
   <span class="font10">fluocinolone </span>
   <span class="font10">function </span>
   <span class="font10">functional </span>
   <span class="font10">glaucoma </span>
   <span class="font10">glycemic </span>
   <span class="font10">green </span>
   <span class="font10">higher </span>
   <span class="font10">hypoglycemic </span>
   <span class="font10">implant </span>
   <span class="font10">induce </span>
   <span class="font10">induced </span>
   <span class="font10">inhibitor </span>
   <span class="font10">intraocular </span>
   <span class="font10">isolated </span>
   <span class="font10">lead </span>
   <span class="font10">letters </span>
   <span class="font10">longer </span>
   <span class="font10">mainly </span>
   <span class="font10">membrane </span>
   <span class="font10">microplasmin </span>
   <span class="font10">microvascular </span>
   <span class="font10">months. </span>
   <span class="font10">need </span>
   <span class="font10">observed </span>
   <span class="font10">panretinal </span>
   <span class="font10">pathways </span>
   <span class="font10">placebo-controlled </span>
   <span class="font10">posterior </span>
   <span class="font10">potent </span>
   <span class="font10">prevention </span>
   <span class="font10">prevents </span>
   <span class="font10">proteins </span>
   <span class="font10">provide </span>
   <span class="font10">pt;} </span>
   <span class="font10">reduced </span>
   <span class="font10">related </span>
   <span class="font10">restore </span>
   <span class="font10">sorbitol </span>
   <span class="font10">standard </span>
   <span class="font10">stromal </span>
   <span class="font10">targets </span>
   <span class="font10">trivaris </span>
   <span class="font10">vein </span>
   <span class="font10">visual </span>
   <span class="font10">well-tolerated </span>
   <span class="font10">widely </span>
  </p>
 </body>
</html>
